Professor Peter Collins
Key publications
- Ichimura, K., Pearson, D.M., Kocialkowski, S., Backlund, L.M., Chan, R., Jones, D.T., and Collins, V.P. (2009). IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol 11, 341-347.
- Jones, D.T., Kocialkowski, S., Liu, L., Pearson, D.M., Ichimura, K., and Collins, V.P. (2009). Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 28, 2119-2123.
- Brada, M., Stenning, S., Gabe, R., Thompson, L.C., Levy, D., Rampling, R., Erridge, S., Saran, F., Gattamaneni, R., Hopkins, K., et al. (2010). Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. J Clin Oncol 28, 4601-4608.
- Jacob, K., Khuong Quang, D.A., Jones, D.T., Witt, H., Lambert, S.R., Albrecht, S., Witt, O., Vezina, C., Shirinian, M., Faury, D., et al. (2011). Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Clin Cancer Res.